Press release from Companies: Hamlet Pharma får nytt snabbt godkännande i Tjeckien

Press release from Companies: Hamlet Pharma får nytt snabbt godkännande i Tjeckien

Press release from Companies: Full speed ahead! – Hamlet Pharma adapts the clinical trial program for stand-alone use

Press release from Companies: Full speed ahead! – Hamlet Pharma adapts the clinical trial program for stand-alone use

Press release from Companies: Full fart framåt! – Hamlet Pharma utvecklar det kliniska prövningsprogrammet ytterligare

Press release from Companies: Brain tumor therapy – A new indication for Hamlet Pharma

Press release from Companies: Brain tumor therapy – A new indication for Hamlet Pharma

Press release from Companies: Teckningsoptioner av serie TO 3 B tecknades till cirka 45% procent och Hamlet Pharma AB (publ) tillförs cirka 5,8 MSEK.

Press release from Companies: Full fart framåt! – En interju med Hamlet Pharmas nya VD

Press release from Companies: Full fart framåt! – En interju med Hamlet Pharmas nya VD

Press release from Companies: Sista dag för handel med teckningsoptioner av serie TO 3 B i Hamlet Pharma AB (publ) är idag, den 27 maj 2022

Market Notices: Market Notice 83/22– Last day of trading in Hamlet Pharma AB’s subscription option HAMLET TO 3 B